Mar 15, 2022 / 05:35PM GMT
Huidong Wang - Barclays Bank PLC, Research Division - Research Analyst
Great. Thank you. Good afternoon, everyone. My name is Gena Wang. I'm a SMID-cap biotech analyst. It's my great pleasure to introduce our next presenting company, Moderna. With us, we have Paul Burton, Chief Medical Officer.
Questions and Answers:
Huidong Wang - Barclays Bank PLC, Research Division - Research AnalystSo Paul, maybe before I ask specific questions, we just saw COVID has some recent change in the past few weeks. What is Moderna's perspective on these?
Paul Burton - Moderna, Inc. - Chief Medical Officer
Yes. Thank you, Gena. Good afternoon, everybody. It's great to be here. Look, we have talked in recent weeks on the last Q call that we felt we would see a period of stability in cases, case counts declining here, certainly in the Northern Hemisphere, as we go into spring and into summer, and then they may rebound.
I would say with the events that we've seen in China, throughout Europe, the resurgence now, resurgence of
Trustpilot
